A comprehensive view of Side Effects/Drug-Related Illnesses. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Teva Pharmaceuticals announces settlement agreement with Attorney General of Florida related to opioid-related claims; Teva will pay US$177M over 15 years and will provide lifesaving Narcan nasal spray valued at US$84M over 10 years

AstraZeneca announces approval in Japan for Ondexxya for patients taking Factor Xa inhibitors, which help prevent blood clots but can lead to uncontrolled bleeding; Ondexxya quickly reverses Factor Xa inhibitors in patients experiencing acute bleeding

Teva Pharmaceuticals reaches agreement with Rhode Island attorney general to settle opioid-related claims; Teva will pay Rhode Island US$21M over 13 years and will provide lifesaving medicine generic Narcan and Suboxone tablets valued at US$78.5M total

Major study with millions of participants finds most mRNA COVID-19 vaccine side effects were mild and faded substantially after one day; study relied on data from self-reported instances of negative side effects between December 2020 and June 2021

Pfizer, under federal judge's orders, releases vaccine safety data previously scheduled to be revealed years later; overall benefit-to-risk ratio remains positive, but new data reportedly show previously unreported deaths occurring after taking vaccine

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count